Intuitive Surgical (NASDAQ:ISRG) EVP Brian Edward Miller Sells 3,500 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the completion of the sale, the executive vice president owned 5,758 shares in the company, valued at approximately $3,310,850. This represents a 37.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Intuitive Surgical Stock Performance

ISRG stock traded up $0.28 on Wednesday, reaching $572.45. The company’s stock had a trading volume of 1,632,272 shares, compared to its average volume of 2,121,198. The firm has a market cap of $205.21 billion, a PE ratio of 75.72, a PEG ratio of 4.94 and a beta of 1.62. The business has a fifty day simple moving average of $476.01 and a two-hundred day simple moving average of $502.00. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.84 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Fiduciary Group LLC lifted its holdings in shares of Intuitive Surgical by 0.9% in the 3rd quarter. Fiduciary Group LLC now owns 22,823 shares of the medical equipment provider’s stock worth $10,207,000 after acquiring an additional 200 shares during the last quarter. Cresset Asset Management LLC boosted its stake in Intuitive Surgical by 5.7% in the third quarter. Cresset Asset Management LLC now owns 8,092 shares of the medical equipment provider’s stock valued at $3,619,000 after acquiring an additional 435 shares in the last quarter. NZS Capital LLC raised its position in shares of Intuitive Surgical by 61.1% in the 3rd quarter. NZS Capital LLC now owns 110,014 shares of the medical equipment provider’s stock valued at $49,202,000 after purchasing an additional 41,708 shares during the last quarter. Legato Capital Management LLC raised its stake in Intuitive Surgical by 23.2% in the 3rd quarter. Legato Capital Management LLC now owns 11,700 shares of the medical equipment provider’s stock worth $5,233,000 after acquiring an additional 2,200 shares during the last quarter. Finally, Level Four Advisory Services LLC increased its holdings in shares of Intuitive Surgical by 23.5% in the third quarter. Level Four Advisory Services LLC now owns 1,204 shares of the medical equipment provider’s stock valued at $538,000 after purchasing an additional 229 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ISRG. Leerink Partners upped their price target on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. BTIG Research upped their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Daiwa Capital Markets increased their target price on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Finally, Evercore ISI increased their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.